Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma
Clinics; 75 (), 2020
OBJECTIVES: Timolol maleate has been reported to be a safer intraocular pressure (IOP) lowering treatment than latanoprost. The United States Food and Drug Administration approved latanoprostene bunod, a nitric oxide-donating prodrug of latanoprost, for lowering IOP. This study compared the safety and ef...
Antihipertensivos/efectos adversos, Método Doble Ciego, Glaucoma de Ángulo Abierto/tratamiento farmacológico, Presión Intraocular, Latanoprost, Hipertensión Ocular/tratamiento farmacológico, Soluciones Oftálmicas, Prostaglandinas F Sintéticas/efectos adversos, Timolol/efectos adversos, Resultado del Tratamiento